Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme -- Ignore unavailable to you. Want to Upgrade?

To: Wayne Rumball who wrote (429)	5/28/1998 9:42:00 AM
From: Frederick Langford	Read Replies (2) \| Respond to of 8798

FYI: 5/28/98 7:47am est - KOOL - 2 13/32 - Thermogenesis Corp. and the New York Blood Center announced that they have received from the U.S. Patent and Trademark Office a Notice of Allowance of claims on their patent application for a method of concentrating and cryopreserving hematopoietic stem and progenitor cells. These life-saving cells are used to reconstitute the hematopoietic and immune system of patients who have undergone high-dose chemotherapy and radiation to combat such diseases as leukemias, lymphomas, diverse inherited anemias, and hypoproliferative stem cell disorders. KOOL has 18.9 million shares outstanding and 59k average volume. Fred